Stella Diagnostics, Inc. (SLDX)
0.01
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Stella Diagnostics EPS Diluted (Quarterly) : -0.0032 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0032 |
| March 31, 2026 | -0.0036 |
| December 31, 2025 | -0.0053 |
| September 30, 2025 | -0.002 |
| June 30, 2025 | -0.0031 |
| March 31, 2025 | -0.0016 |
| December 31, 2024 | -0.0006 |
| September 30, 2024 | -0.0007 |
| June 30, 2024 | -0.001 |
| March 31, 2024 | -0.0008 |
| December 31, 2023 | -0.004 |
| September 30, 2023 | -0.002 |
| June 30, 2023 | -0.001 |
| March 31, 2023 | -0.0077 |
| December 31, 2022 | -0.0035 |
| September 30, 2022 | -0.0075 |
| June 30, 2022 | -0.0011 |
| March 31, 2022 | -0.0404 |
| September 30, 2021 | -0.002 |
| June 30, 2021 | -0.0046 |
| March 31, 2021 | -0.0039 |
| September 30, 2020 | -0.0678 |
| June 30, 2020 | -0.0091 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0112 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0008 |
| March 31, 2019 | -0.0086 |
| March 31, 2018 | -1.50 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| September 30, 2015 | 11.50 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -1.50 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -1.50 |
| December 31, 2013 | -1.00 |
| September 30, 2013 | -6.50 |
| June 30, 2013 | -2.50 |
| March 31, 2013 | -50.00 |
| June 30, 2012 | -43.50 |
| March 31, 2012 | -282.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.0004 |
| DataMeds AI, Inc. | -7.132 |
| Interpace Biosciences, Inc. | 0.0285 |
| Medical Marijuana, Inc. | 0.00 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.978M |
| Revenue (Quarterly) | 0.5011M |
| Total Expenses (Quarterly) | 1.479M |
| Enterprise Value | 21.03M |
| Gross Profit Margin (Quarterly) | -14.09% |
| Profit Margin (Quarterly) | -195.2% |
| Earnings Yield | -141.0% |
| Normalized Earnings Yield | -141.00 |